Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
21
pubmed:dateCreated
1990-12-7
pubmed:abstractText
Familial hypercholesterolemia is an inherited disease in humans that is associated with coronary artery disease and is caused by a deficiency of the receptor that mediates the internalization of low density lipoprotein (LDL). We have used an animal model for familial hypercholesterolemia, the Watanabe heritable hyperlipidemic (WHHL) rabbit, to design a therapeutic approach for this disease, which attempts to correct the hepatic defect in LDL receptor expression. Hepatocytes were harvested from WHHL rabbits, plated in primary cultures, and exposed to recombinant retroviruses capable of efficiently transferring a functional human LDL receptor gene. Genetically modified cells were harvested and infused into the portal vein of WHHL recipients, who were analyzed for metabolic consequences of human LDL receptor expression. Each animal exhibited a statistically significant decrease in total serum cholesterol 2-6 days after transplantation, with an eventual return to pretreatment levels. Proviral DNA sequences and virus-directed transcripts were detected in liver tissue 24 hr after transplantation. In situ hybridization demonstrated provirus expression in a small population of hepatocytes distributed in periportal sections of the liver. This study illustrates the potential of somatic gene therapy in ameliorating hyperlipidemia associated with familial hypercholesterolemia.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/2236051-2454468, http://linkedlifedata.com/resource/pubmed/commentcorrection/2236051-2665860, http://linkedlifedata.com/resource/pubmed/commentcorrection/2236051-3010466, http://linkedlifedata.com/resource/pubmed/commentcorrection/2236051-3548303, http://linkedlifedata.com/resource/pubmed/commentcorrection/2236051-3768959, http://linkedlifedata.com/resource/pubmed/commentcorrection/2236051-3856094, http://linkedlifedata.com/resource/pubmed/commentcorrection/2236051-6091052, http://linkedlifedata.com/resource/pubmed/commentcorrection/2236051-6264472, http://linkedlifedata.com/resource/pubmed/commentcorrection/2236051-6282866, http://linkedlifedata.com/resource/pubmed/commentcorrection/2236051-6285345, http://linkedlifedata.com/resource/pubmed/commentcorrection/2236051-6306464, http://linkedlifedata.com/resource/pubmed/commentcorrection/2236051-6390206, http://linkedlifedata.com/resource/pubmed/commentcorrection/2236051-6438436, http://linkedlifedata.com/resource/pubmed/commentcorrection/2236051-6957885, http://linkedlifedata.com/resource/pubmed/commentcorrection/2236051-7406953, http://linkedlifedata.com/resource/pubmed/commentcorrection/2236051-7409195
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0027-8424
pubmed:author
pubmed:issnType
Print
pubmed:volume
87
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
8437-41
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1990
pubmed:articleTitle
Temporary amelioration of hyperlipidemia in low density lipoprotein receptor-deficient rabbits transplanted with genetically modified hepatocytes.
pubmed:affiliation
Department of Internal Medicine, Howard Hughes Medical Institute, University of Michigan, Ann Arbor 48109.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't